BIOMARIN PHARMACEUTICAL INC Employee Count
The employee counts BIOMARIN PHARMACEUTICAL INC states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 3,221; Filing 2026-02-26; Lease expense per employee $4,056.19.
- 2024-12-31: Employees (as filed) 3,040; Filing 2025-02-24; Lease expense per employee $5,217.76.
- 2023-12-31: Employees (as filed) 3,401; Filing 2024-02-26; Lease expense per employee $5,940.90.
- 2022-12-31: Employees (as filed) 3,082; Filing 2023-02-27; Lease expense per employee $5,415.31.
- Available history
- 2008-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 3,221 | 2026-02-26 | $4,056.19 total lease cost |
| 2024-12-31 | 3,040 | 2025-02-24 | $5,217.76 total lease cost |
| 2023-12-31 | 3,401 | 2024-02-26 | $5,940.90 total lease cost |
| 2022-12-31 | 3,082 full-time | 2023-02-27 | $5,415.31 total lease cost |
| 2021-12-31 | 3,045 full-time | 2022-02-25 | $5,774.71 total lease cost |
| 2020-12-31 | 3,059 full-time | 2021-02-26 | $5,413.53 total lease cost |
| 2019-12-31 | 3,001 full-time | 2020-02-27 | $5,413.86 total lease cost |
| 2018-12-31 | 2,849 full-time | 2019-02-28 | $4,282.20 rent expense, net |
| 2017-12-31 | 2,581 full-time | 2018-02-26 | $4,416.89 rent expense, net |
| 2016-12-31 | 2,293 full-time | 2017-02-27 | $5,058.87 rent expense, net |
| 2015-12-31 | 2,158 full-time | 2016-02-29 | $4,309.55 rent expense, net |
| 2014-12-31 | 1,681 full-time | 2015-03-02 | $4,699.58 rent expense, net |
| 2013-12-31 | 1,341 full-time | 2014-02-26 | $7,755.41 rent expense, net |
| 2012-12-31 | 1,089 full-time | 2013-02-26 | $9,274.56 rent expense, net |
| 2011-12-31 | 1,002 full-time | 2012-02-22 | $5,988.02 rent expense, net |
| 2010-12-31 | 871 full-time | 2011-02-24 | $5,855.34 rent expense, net |
| 2009-12-31 | 720 full-time | 2010-02-26 | $5,972.22 rent expense, net |
| 2008-12-31 | 649 full-time | 2009-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |